Dachaigh › Aillse Sgamhain Neo-chealla-beag › Ohio › Toledo
Sgrùdaidhean clionaigeach Aillse Sgamhain Neo-chealla-beag ann an Toledo, OH
Tha 17 sgrùdaidhean airson Aillse Sgamhain Neo-chealla-beag a’ lorg phàirtichean aig làraichean ann agus timcheall air Toledo (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A’ fastadhÌre 2
- Mercy Health - Perrysburg Cancer Center /ID# 270536, Perrysburg · 8 mìle air falbh
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
A’ fastadhÌre 3
- ProMedica Flower Hospital, Sylvania · 9 mìle air falbh
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
A’ fastadhÌre 3
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · 8 mìle air falbh
- ProMedica Flower Hospital, Sylvania · 9 mìle air falbh
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
A’ fastadhÌre 1
- Site 06, Maumee · 9 mìle air falbh
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
A’ fastadhÌre 3
- Taylor Cancer Research Center, Maumee · 9 mìle air falbh
Pan-tumor MRD Study
A’ fastadhSgrùdadh amharc
- Taylor Cancer Research Center, Maumee · 9 mìle air falbh
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
A’ fastadhÌre 3
- Research Site, Toledo
- Research Site, Maumee · 9 mìle air falbh
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
A’ fastadhSgrùdadh amharc
- Toledo Clinic Cancer Center, Toledo
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
A’ fastadhÌre 2
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · 8 mìle air falbh
- ProMedica Flower Hospital, Sylvania · 9 mìle air falbh
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
A’ fastadhÌre 1/2
- Taylor Cancer Research Center, Maumee · 9 mìle air falbh
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A’ fastadhÌre 3
- Research Site, Maumee · 9 mìle air falbh
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
A’ fastadhÌre 2
- ProMedica Flower Hospital, Sylvania · 9 mìle air falbh
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
A’ fastadhÌre 2/3
- ProMedica Flower Hospital, Sylvania · 9 mìle air falbh
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
A’ fastadhÌre 2
- ProMedica Flower Hospital, Sylvania · 9 mìle air falbh
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- Taylor Cancer Research Center, Maumee · 9 mìle air falbh
GEMINI-NSCLC: NSCLC Biomarker Study
A’ fastadhSgrùdadh amharc
- Taylor Cancer Research Center, Maumee · 9 mìle air falbh
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
A’ fastadhÌre 1/2
- Taylor Cancer Research Center (site 204), Maumee · 9 mìle air falbh
Sgrùdaidhean Aillse Sgamhain Neo-chealla-beag ann am bailtean eile
- Houston, TX145 sgrùdaidhean
- New York City, NY121 sgrùdaidhean
- Arlington, VA104 sgrùdaidhean
- Nashville, TN97 sgrùdaidhean
- Boston, MA90 sgrùdaidhean
- Los Angeles, CA87 sgrùdaidhean
- St. Louis, MO73 sgrùdaidhean
- Chicago, IL61 sgrùdaidhean
- Baltimore, MD60 sgrùdaidhean
- San Antonio, TX59 sgrùdaidhean
- Columbus, OH57 sgrùdaidhean
- Washington, DC55 sgrùdaidhean
Sgrùdaidhean eile ann an Toledo
- Cancer Ovarian12 sgrùdaidhean
- Ailseachadh nan Sgamhan11 sgrùdadh
- Ailse metastatach10 sgrùdaidhean
- Buailteach9 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil8 sgrùdaidhean
- Ailse Endometrial8 sgrùdaidhean
- Melanoma8 sgrùdaidhean
- Cancer Pancreatic8 sgrùdaidhean
- Aillse Prostata7 sgrùdaidhean
- Ailseas Esophageach7 sgrùdaidhean
- Buille ischemach7 sgrùdaidhean
- Fàilligeadh a' Chridhe7 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.